PharmabioticsGlobal 2017 is organized by the Pharmabiotics Research Institute in Paris 15th to the 17th of March. ILYA Pharma will do a presentation at the Startup Showcase session together with other companies using the microbiome to develop new innovative treatments.
“It is so exiting to be part of this. Using living organisms as pharmaceutical products is the next thing and our technology where lactic acid bacteria are genetically modified to deliver human effector protein is the next-generation biological drugs. For us it is important to be here and be a part of the discussions since this is an emerging field moving fast forward and the community works close with the regulating authorities EMA and FDA”, says Evelina Vågesjö.